TY  - GEN
AU  - Byrgazov,Konstantin
AU  - Lucini,Chantal Blanche
AU  - Valent,Peter
AU  - Hantschel,Oliver
AU  - Lion,Thomas
TI  - BCR-ABL1 compound mutants display differential and dose-dependent responses to ponatinib
SN  - 1592-8721
PY  - 2019///0724
KW  - Alleles
KW  - Amino Acid Substitution
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Dose-Response Relationship, Drug
KW  - Drug Resistance, Neoplasm
KW  - genetics
KW  - Fusion Proteins, bcr-abl
KW  - Gene Expression
KW  - Humans
KW  - Imidazoles
KW  - Mutation
KW  - Pharmacogenomic Testing
KW  - Pharmacogenomic Variants
KW  - Protein Kinase Inhibitors
KW  - Pyridazines
N1  - Publication Type: Letter; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3324/haematol.2017.176347
ER  -